Description: Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. The Company's segments include New Zealand, which includes all activities controlled by entities or employees based in New Zealand; North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, and Asia-Pacific, which includes all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong. Its products include respiratory humidifiers, single-use and reusable chambers and breathing circuits, infant resuscitators, infant warmers and accessories. In addition, the Company offers hardware and consumables.
Home Page: www.fphcare.com
FPH Technical Analysis
Fidelity Select Portfolios
,
Phone:
800-544-8544
Officers
| Name | Title |
|---|---|
| Mr. Lewis G. Gradon | MD, CEO & Exec. Director |
| Ms. Lyndal York | Chief Financial Officer |
| Dr. Andrew Somervell | VP of Products & Technology |
| Hayden Brown | Investor Relations Mang. |
| Karen Knott | Gen. Mang. of Corp. Communications |
| Mr. Paul N. Shearer B.Com. | Sr. VP of Sales & Marketing |
| Ms. Nicola Talbot | VP of HR |
| Mr. Jonathan Rhodes | VP of Supply Chain, Facilities & Sustainability |
| Mr. Marcus Driller | VP of Corp. & Company Sec. |
| Chris Crone | Gen. Mang. of Airvo Optiflow |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| Forward PE: | 53.7634 |
|---|---|
| Trailing PE: | 56.09 |
| Price-to-Book MRQ: | 9.0558 |
| Price-to-Sales TTM: | 8.3634 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 6769 |